Alarm as 10 HIV drugs out of stock
Health & Science
By
Anyango Otieno and Graham Kajilwa
| Oct 07, 2020
There is a shortage of 10 crucial HIV/Aids drugs as a result of Covid-19 pandemic, the UN has warned.
In a latest report by UNAids, at least 10 anti-retroviral therapy (ART) medication is in short supply.
They include Tenofovir, Abacavuir, Cotrimoxazole suspension, Ritonavir tablets, Nevirapine suspension (for new born), Zidovudine solution, Zidovudine/lamivudine (AZT/3TC), Lopinavir/ Ritonavir(LPV/r) 100/25 mg, and LPV/r pellets 40/10 formulation.
A model by the World Health Organisation and the Joint United Nations Programmes on HIV and Aids (UNAids) estimated a six-month disruption of antiretroviral therapy could lead to more than 500 000 additional Aids-related deaths, including from tuberculosis, in sub-Saharan Africa in 2020–2021.
READ MORE
Why AI is gaining prominence in Africa's new investment agenda
New push to formalise garbage collection SMEs
The power of patience, psychology and strategy in debt recovery
Motivational speakers: When they sell you false business hopes
Africa Summit win for Kenya and continent, but on whose terms?
Youth gain skills in electronics repair and e-waste management
From Boeing cockpit to truck seat: Building Africa's logistics backbone
France says G7 finance talks 'frank, sometimes difficult'
Africa banks on continental trade agreement to rev up investments
In Kenya, persons living with HIV have already confirmed a short supply of Cotrimoxazole, which is sold as Septrin.